SLC11A1 and neoplasm: Additionally, tumor mutation burden (TMB) analysis revealed that low SLC11A1 expression usually accompanied by a lower TMB, and a key role for TMB is considered in the generation of immunogenic neopeptides displayed on tumor cells is its role in driving the expression of MHC molecules on tumor cells (Figure 3G).